The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- Shared Belief Looking to Retain His Throne
- Big Three Clash in Rich Travers Stakes
- Champion English Channel Relocates to Calumet
- Wise Dan to Make Return in Bernard Baruch
- Storm and a Half to Stand in Iowa
- Tiz Wonderful Colt Sells for OKC Sale Record
- Unbeaten Taghrooda Heads Yorkshire Oaks
- Consignors Provide Keeneland Showing Schedule
- Haskin's Top Sprinters of the Last 50 Years
- New Mexico Owner/Breeder Danley Dies